Current Status and Future Directions in the Treatment of Peritoneal Dissemination from Colorectal Carcinoma

Surgical Oncology Clinics of North America

Volumn 21, Issue 4, 2012, Pages 611-623

  Elias, Dominique ^a   Quenet, François ^b   Goéré, Diane ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b CENTRE VAL D AURELLE   (France)

Author keywords

Colon; Cytoreductive surgery; Intraperitoneal chemohyperthermia; Peritoneal carcinomatosis; Rectum

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MITOMYCIN C; OXALIPLATIN;

CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CARCINOMATOUS PERITONITIS; CLINICAL EFFECTIVENESS; COLORECTAL CARCINOMA; CYTOREDUCTIVE SURGERY; DRUG EFFICACY; HUMAN; HYPERTHERMIC THERAPY; NONHUMAN; OVERALL SURVIVAL; PERITONEUM METASTASIS; REVIEW; RISK BENEFIT ANALYSIS; TREATMENT INDICATION;

ANTINEOPLASTIC AGENTS; CARCINOMA; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COLORECTAL NEOPLASMS; HUMANS; HYPERTHERMIA, INDUCED; PATIENT SELECTION; PERITONEAL NEOPLASMS; PREOPERATIVE CARE;

EID: 84866776715     PISSN: 10553207     EISSN: 15585042     Source Type: Journal    
DOI: 10.1016/j.soc.2012.07.014     Document Type: Review

References (26)

1. Chu D.Z., Lang N.P., Thompson C., et al. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer 1989, 63:364-367.
2. Sadeghi B., Arvieux C., Glehen O., et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 2000, 88:358-363.
3. Jayne D.G., Fook S., Loi C., et al. Peritoneal carcinomatosis from colorectal cancer. Br J Surg 2002, 89:1545-1550.
4. Franko J., Hhi Q., Goldman C., et al. Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of NCCTG's phase III trials N9741 and N9841. J Clin Oncol 2011, 29(Suppl). [abstract: 3571].
5. Saltz L., Clarke S., Diaz-Rubio E., et al. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol 2008, 26:1013-1019.
6. Mulsow J., Merkel S., Agaimy A., et al. Outcomes following surgery for colorectal cancer with synchronous peritoneal metastases. Br J Surg 2011, 98:1785-1791.
7. Kobayashi K., Enomoto M., Higushi T., et al. Validation and clinical use of the Japanese classification of colorectal metastases: benefit of surgical cytoreduction even without intraperitoneal chemotherapy. Dig Surg 2010, 27:473-480.
8. Verwaal V.J., van Ruth S., de Bree E., et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003, 21:3737-3743.
9. Klaver Y.L., Lemmens V.E., Creemers G.J., et al. Population-based survival of patients with peritoneal carcinomatosis from colorectal origin in the era of increasing use of palliative chemotherapy. Ann Oncol 2011, 22:2250-2256.
10. Elias D., Gilly F., Boutitie F., et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol 2010, 28:63-68.
11. Hompes D., Boot H., Van Tinteren H., et al. Unresectable peritoneal carcinomatosis from colorectal cancer: a single center experience. J Surg Oncol 2011, 104:269-273.
12. Quenet F., Goéré D., Mehta S.S., et al. Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis. Ann Surg 2011, 254:294-301.
13. Armour E.Z.P., McEachern D., Wang G., et al. Sensitivity of human cells to mild hyperthermia. Cancer Res 1993, 53:2740-2744.
14. Elias D., Antoun S., Goharin A., et al. Research on the best chemohyperthermia technique for treatment of peritoneal carcinomatosis after complete resection. Int J Surg Investig 2000, 1:431-439.
15. Koga S., Hamazoe R., Maeta M., et al. Treatment of implanted peritoneal cancer in rats by continuous hyperthermic peritoneal perfusion in combination with an anticancer drug. Cancer Res 1984, 44:1840-1842.
16. Pelz J., Doerfer J., Dimmler A., et al. Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion in experimental investigations. BMC Cancer 2006, 2:162-169.
17. van de Vaart P., van der Vange N., Zoetmulder F., et al. Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin-DNA adduct formation in patients and ovarian cancer cell lines. Eur J Cancer 1998, 34:148-154.
18. Elias D., Lefèvre J., Chevalier J., et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 2009, 27:681-685.
19. Goéré D, Tzanis D, Gava V, et al. Can patients with colorectal peritoneal carcinomatosis be cured after cytoreduction and intraperitoneal chemotherapy? Ann Surg, in press.
20. Elias D. Peritoneal carcinomatosis or liver metastases from colorectal cancer: similar standards for a curative surgery?. Ann Surg Oncol 2004, 11:122-123.
21. Elias D., Benizri E., Pocard M., et al. Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer. Eur J Surg Oncol 2006, 32:632-636.
22. Passot G., Vaudoyer D., Cotte E., et al. Ann Surg 2010, 256:125-129.
23. da Silva R.G., Sugarbaker P.H. Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer. J Am Coll Surg 2006, 203:878-886.
24. Elias D., Soudka A., Fayard F., et al. Variation in the Peritoneal Cancer Index scores between surgeons and according to when they are determined (before or after cytoreductive surgery). Eur J Surg Oncol 2012, 38(6):503-508.
25. Maggiori L., Goéré D., Tzanis D., et al. Should patients with peritoneal carcinomatosis of colorectal origin with synchronous liver metastases be treated with a curative intent? A case control study. Ann Surg 2012, in press.
26. Elias D., Goere D., Di Pietrantonio D., et al. Results of systematic second-look surgery in patients at high risk of developing colorectal peritoneal carcinomatosis. Ann Surg 2008, 247:445-450.